LNC
DXCM icon

Lincoln National Corp’s DexCom DXCM Stock Holding History

Lincoln National Corp’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,537
Closed -$352K – 300
2024
Q1 		$352K Buy
2,537
+743
+41% +$93.4K 0.01% 882
2023
Q4 		$223K Sell
1,794
-511
-22% -$52.2K ﹤0.01% 1003
2023
Q3 		$215K Sell
2,305
-22
-0.9% -$2.48K ﹤0.01% 937
2023
Q2 		$299K Buy
2,327
+95
+4% +$11.5K 0.01% 791
2023
Q1 		$259K Buy
2,232
+103
+5% +$11.5K 0.01% 825
2022
Q4 		$241K Buy
+2,129
New +$234K 0.01% 802
2022
Q2 		– Sell
-2,028
Closed -$259K – 882
2022
Q1 		$259K Hold
2,028
– – 0.01% 767
2021
Q4 		$272K Hold
2,028
– – 0.01% 748
2021
Q3 		$277K Buy
2,028
+8
+0.4% +$1.01K 0.01% 714
2021
Q2 		$216K Buy
+2,020
New +$194K ﹤0.01% 786

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lincoln National Corp's DXCM Position: Q2 2024 in Review

Lincoln National Corp sold out of DexCom (DXCM) in Q2 2024, closing a stake of 2,537 shares — an estimated $352K sold.

Lincoln National Corp first reported a position in DXCM in Q2 2021 and held it in 10 quarters. The position peaked at $352K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Lincoln National Corp reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 2,537 DexCom shares in Q2 2024, an estimated $352K.
  • Lincoln National Corp first reported a position in DexCom in Q2 2021 and held it in 10 quarters.
  • Lincoln National Corp's DexCom position peaked at $352K in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.